Skip to main content

Table 2 Characteristics of included patients

From: Evaluation of scoring systems without endoscopic findings for predicting outcomes in patients with upper gastrointestinal bleeding

  Patients (N = 590) Percentage (%)
Gender
 Female 215 36.4
Age
 Less than 60 166 28.1
 60 ~ 79 133 22.5
 More than 80 291 49.3
History of disease
 Liver disease 41 6.9
 Renal disease 3 0.5
 Heart disease 337 57.1
 Metastatic malignancy 6 1
Presenting symptoms
 Melena 288 48.8
 Hematemesis 147 24.9
 Hematochezia 135 22.9
 Syncope 20 3.4
Medication
 No 272 46.1
 Aspirin or other antiplatelet such as clopidogrel 202 34.2
 Warfarin and other anticoagulant 90 15.3
 NSAIDs 26 4.4
Time for endoscopic examination
 Less than 6 h 233 39.5
 6 ~ 24 h 208 35.3
 24 ~ 48 h 143 24.2
 After 48 h 4 0.7
 No endoscopy 2 0.3
Transfusion
 No 141 23.9
 Yes 449 76.1
Hemostatic procedures
 No 386 65.4
 Endoscopic intervention 191 32.4
 Radiologic intervention 13 2.2
 Surgery 0 0
30-day mortality
 Survival 565 95.8
 Death 25 4.2
  1. NSAIDs non-steroidal anti-inflammatory drugs